Trials / Sponsors / Galmed Research and Development, Ltd.
Galmed Research and Development, Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment Hepatic Impairment | Phase 1 | 2020-02-13 |
| Suspended | A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) Nonalcoholic Steatohepatitis (NASH) | Phase 3 | 2019-09-23 |
| Completed | A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NAS Fatty Liver, Non-Alcoholic Steatohepatitis, Liver Diseases | Phase 2 | 2015-04-29 |